Loading...
Docoh

Aytu BioPharma (AYTU)

676 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
AYTU Aytu BioPharma Inc
1 Jul 22
Entry into a Material Definitive Agreement
4:00pm
4
AYTU Aytu BioPharma Inc
1 Jul 22
AYTU BIOPHARMA / VIVIAN H LIU ownership change
3:12pm
3
AYTU Aytu BioPharma Inc
1 Jul 22
AYTU BIOPHARMA / VIVIAN H LIU ownership change
3:04pm
8-K
AYTU Aytu BioPharma Inc
29 Jun 22
Aytu BioPharma Announces the Appointment of Vivian Liu to the Company’s Board of Directors
8:05am
EFFECT
AYTU Aytu BioPharma Inc
23 Jun 22
Notice of effectiveness
12:15am
S-3
AYTU Aytu BioPharma Inc
8 Jun 22
Shelf registration
4:06pm
8-K
AYTU Aytu BioPharma Inc
26 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00pm
8-K
AYTU Aytu BioPharma Inc
20 May 22
Submission of Matters to a Vote of Security Holders
7:03am
8-K
AYTU Aytu BioPharma Inc
16 May 22
Aytu BioPharma Reports Third Quarter 2022 Financial Results and Outlines Key Strategic Priorities
4:20pm
10-Q
2022 Q3
AYTU Aytu BioPharma Inc
15 May 22
Quarterly report
8:00pm
8-K
AYTU Aytu BioPharma Inc
8 May 22
Amendments to Articles of Incorporation or Bylaws
8:00pm
8-K
AYTU Aytu BioPharma Inc
25 Apr 22
Aytu BioPharma Announces Positive Preclinical Data in Ventilator-Associated Pneumonia with its Novel, Proprietary Healight™ Delivery Technology
8:01am
8-K
AYTU Aytu BioPharma Inc
19 Apr 22
Aytu BioPharma Announces Fast Track Designation Granted to
8:11am
DEFA14A
AYTU Aytu BioPharma Inc
7 Apr 22
Additional proxy soliciting materials
8:13am
DEF 14A
AYTU Aytu BioPharma Inc
7 Apr 22
Definitive proxy
8:09am
8-K
AYTU Aytu BioPharma Inc
23 Mar 22
Aytu BioPharma Announces FDA Orange Book Listing of Newly Issued Patent for About Cotempla XR-ODT
8:08am
8-K
AYTU Aytu BioPharma Inc
3 Mar 22
Aytu BioPharma Announces Pricing of $7.6 Million Registered Offering
6:32pm
424B2
AYTU Aytu BioPharma Inc
3 Mar 22
Prospectus for primary offering
6:24pm
424B5
AYTU Aytu BioPharma Inc
2 Mar 22
Prospectus supplement for primary offering
9:17pm
8-K
AYTU Aytu BioPharma Inc
2 Mar 22
Aytu BioPharma Announces AR101 Granted Orphan Designation in Europe for the Treatment of Ehlers-Danlos Syndrome
8:10am